Working closely with other venture capitalists with overlapping interests
HOUSE_OVERSIGHT_024054.jpg
This document is page 43 of a confidential investment memorandum describing the 'Deal Sourcing & Investment Process' for a fund referred to as 'NLV'. It details the Fund Managers' strategy of tracking biopharma companies (specifically in Oncology, Infectious Disease, and CNS) and leveraging a high-level network of industry executives and scientists to identify investment opportunities. The page bears a House Oversight Bates stamp, indicating it was part of a congressional investigation.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship